"Le Centre Hospitalier Universitaire de Toulouse, constitué de plusieurs établissements répartis au nord et au sud de la ville, est un lieu d’accueil, d’hébergement et de soins au service de tous ceux qui, à un certain moment de leur vie, sont confrontés à la maladie et à la souffrance."

During the past decade, CHU Toulouse conducted 444 clinical trials. In the 10-year time frame, 444 clinical trials started and 21 clinical trials were completed, i.e. on average, 4.7% percent of trials that started reached the finish line to date. In the past 5 years, 239 clinical trials started and 13 clinical trials were completed. i.e. 5.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Toulouse" #1 sponsor was "University Hospital, Toulouse" with 155 trials, followed by "Nantes University Hospital" with 41 trials sponsored, "University Hospital, Bordeaux" with 32 trials sponsored, "Rennes University Hospital" with 16 trials sponsored and "Centre Hospitalier Universitaire de Nice" with 16 trials sponsored. Other sponsors include 318 different institutions and companies that sponsored additional 154 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Toulouse" #1 collaborator was "Ministry of Health, France" with 24 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 12 trials as a collaborator, "National Cancer Institute, France" with 7 trials as a collaborator, "University Hospital, Grenoble" with 6 trials as a collaborator and "Pfizer" with 5 trials as a collaborator. Other collaborators include 347 different institutions and companies that were collaborators in the rest 268 trials.

According to Clinical.Site data, the most researched conditions in "CHU Toulouse" are "Multiple Myeloma" (13 trials), "Parkinson Disease" (11 trials), "COVID-19" (8 trials), "Heart Failure" (7 trials) and "Multiple Sclerosis" (6 trials). Many other conditions were trialed in "CHU Toulouse" in a lesser frequency.

Most popular intervention types in "CHU Toulouse" are "Drug" (194 trials), "Other" (156 trials), "Device" (103 trials), "Procedure" (67 trials) and "Biological" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "placebo" (9 trials), "Questionnaire" (8 trials), "Dexamethasone" (6 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "CHU Toulouse" are 544 trials for "All" genders, 27 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are 217 active trials in "CHU Toulouse". 21 are not yet recruiting, 156 are recruiting, 39 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 258 completed trials in CHU Toulouse, undefined suspended trials, and 45 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Toulouse, 8 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 229 trials that are defined as “Not Applicable".

CHU Toulouse has several departments that took part in Clinical trials: "Hopital Purpan Service d'Hématologie Clinique" - 13 trials